The possibility of harmonizing the recombinant erythropoietin specific activity determination method with European Pharmacopoeia

by A. K. Yakovlev, L. A. Gayderova, V. N. Podkuiko, R. A. Volkova, N. A. Alpatova, Yu. V. Olefir
Published 2017-05-01

Studying of the standardization principles of pharmacological activity of recombinant erythropoietin preparations

by A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, E. L. Postnova, E. I. Yurchikova, T. A. Batuashvili, R. A. Volkova, V. N. Podkuiko, Yu. V. Olefir
Published 2017-05-01

Approaches to Reduce Adverse Effect of Vaccinia Virus in Orally Immunized Mice

by D. O. Galakhova, Ar. A. Sergeev, E. V. Shevtsova, Al. A. Sergeev, A. S. Zamedyanskaya, K. A. Titova, L. N. Shishkina, L. E. Bulychev, S. V. Borisevich, V. N. Podkuiko, A. P. Pirozhkov, A. V. Koval’Chuk, Ya. V. Polyansky, E. Yu. Vakhnov, V. V. Perekrest, V. A. Shevtsov, A. P. Agafonov, A. N. Sergeev
Published 2016-03-01